Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Berna Biotech Paying EUR279M In Cash, Shares For Rhein Biotech

May 24, 2002

By Cormac Sheridan

Speedel Moves SPP 301 Into Phase II Pilot Studies

May 22, 2002

By Cormac Sheridan

Speedel Moves SPP 301 Into Phase II Pilot Studies

May 22, 2002

By Cormac Sheridan

Denmark's Genesto Raises DKK40M Through First Round

May 15, 2002

By Cormac Sheridan

CMC Biotech Raises DKK300M For Contract Manufacturing

May 15, 2002

By Cormac Sheridan

ESBATech Raises CHF10.5M For Yeast Cell Screening Assays

May 15, 2002

By Cormac Sheridan

Denmark's Genesto Raises DKK40M Through First Round

May 15, 2002

By Cormac Sheridan

ESBATech Raises CHF10.5M For Yeast Cell Screening Assays

May 15, 2002

By Cormac Sheridan

CMC Biotech Raises DKK300M For Contract Manufacturing

May 15, 2002

By Cormac Sheridan

Personal Chemistry Purchases ESyTech To Extend Platform

May 8, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...